The treatment of PD is focused on the drug therapy including levodopa, catechol-o-methyltransferase inhibitors (COMT), monoamine oxidase type B inhibitor (MAOB), etc. (Ogawa et al., 2022). The gene discussed is MAOB; the disease is Parkinson disease.